Document is current
Any future updates will be listed below
-
Authors
Frade-Sosa, Beatriz https://orcid.org/0000-0002-5867-8434
Ponce, Andrés https://orcid.org/0000-0003-3068-5752
Ruiz-Ortiz, Estíbaliz
De Moner, Noemí
Gómara, María J.
Azuaga, Ana Belén
Sarmiento-Monroy, Juan C. https://orcid.org/0000-0002-8426-7268
Morlà, Rosa https://orcid.org/0000-0002-2892-6142
Ruiz-Esquide, Virginia https://orcid.org/0000-0002-2657-6601
Macías, Laura https://orcid.org/0000-0002-8314-3087
Sapena, Nuria
Tobalina, Lola
Ramirez, Julio
Cañete, Juan D. https://orcid.org/0000-0003-2606-0573
Yague, Jordi https://orcid.org/0000-0002-1935-4488
Auge, Josep M. https://orcid.org/0000-0001-6383-7308
Gomez-Puerta, José A. https://orcid.org/0000-0001-8177-702X
Viñas, Odette https://orcid.org/0000-0001-8488-9975
Haro, Isabel https://orcid.org/0000-0001-8677-2340
Sanmarti, Raimon https://orcid.org/0000-0002-8864-3806
-
Funding
Funding for this research was provided by:
Openbanak
Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (PID2021-122216OB-I00)
- License Information
-
More Information
Article History
Received: 15 November 2023
Accepted: 6 February 2024
First Online: 2 March 2024
Declarations
:
: Beatriz Frade-Sosa received support for attending meetings and/or speaker honoraria from Pfizer, AbbVie, Lilly, BMS, Galápagos, Sandoz and GSK. Laura Macías received support for attending meetings and/or travel from Diasorin in 19 October (LabClin Congress). Juan Camilo Sarmiento-Monroy received support for attending meetings and/or speaker honoraria from Pfizer, AbbVie, Lilly, BMS, Galápagos, Astrazeneca and GSK. Jose A. Gómez-Puerta received speaker honoraria from AbbVie, BMS, Galápagos, GSK, Lilly, Pfizer, Sanofi and Roche. Raimon Sanmartí received speaker honoraria and/or investigation grants from AbbVie, BMS, Gebro-Pharma, Lilly, MSD, Pfizer, Sandoz. Sanofi and Roche. Andrés Ponce, Estíbaliz Ruiz, Noemi de Moner, María J Gómara, Ana Belén Azuaga, Rosa Morlà, Virginia Ruiz-Esquide, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep M. Augé, Odette Viñas and Isabel Haro declare they have no conflicts of interest. No pharmaceutical companies have participated or influenced the development of this manuscript.
: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of the Hospital Clinic of Barcelona (Reg. HCB20210783). Informed consent was obtained from all patients before enrolment in the study.
